I agree that this site is using cookies. You can find further informations here.
X
Xepapadaki, Eva
25  results:
Search for persons X
?
1

High-Density Lipoprotein in Metabolic Disorders and Beyond:..:

Zvintzou, Evangelia ; Xepapadaki, Eva ; Skroubis, George...
Pharmaceuticals.  16 (2023)  6 - p. 855 , 2023
Link: https://doi.org/10.3390/..
 
?
2

Benefits of a fixed-dose combination of standardized P. mum..:

Sagiadinou, Eleftheria C. ; Karavia, Eleni A. ; Xepapadaki, Eva...
Phytomedicine Plus.  2 (2022)  3 - p. 100317 , 2022
Link: https://doi.org/10.1016/..
 
?
3

High density lipoprotein in atherosclerosis and coronary he..:

Zvintzou, Evangelia ; Karampela, Dimitra Sotiria ; Vakka, Aggeliki...
Vascular Pharmacology.  141 (2021)  - p. 106928 , 2021
Link: https://doi.org/10.1016/..
 
?
4

HDL and type 2 diabetes: the chicken or the egg?:

Xepapadaki, Eva ; Nikdima, Ioanna ; Sagiadinou, Eleftheria C...
Diabetologia.  64 (2021)  9 - p. 1917-1926 , 2021
Link: https://doi.org/10.1007/..
 
?
5

Tissue-specific functional interaction between apolipoprote..:

Xepapadaki, Eva ; Nikdima, Ioanna ; Zvintzou, Evangelia..
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.  1866 (2021)  3 - p. 158859 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Isoform and tissue dependent impact of apolipoprotein E on ..:

Kalogeropoulou, Christina ; Hatziri, Aikaterini ; Xepapadaki, Eva...
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.  1865 (2020)  2 - p. 158551 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Adrenoceptor‐related decrease in serum triglycerides is ind..:

Konstandi, Maria ; Kypreos, Kyriakos E. ; Matsubara, Tsutomu...
The FEBS Journal.  286 (2019)  21 - p. 4328-4341 , 2019
Link: https://doi.org/10.1111/..
 
?
8

Τhe Antioxidant Function of HDL in Atherosclerosis:

Xepapadaki, Eva ; Zvintzou, Evangelia ; Kalogeropoulou, Christina..
Angiology.  71 (2019)  2 - p. 112-121 , 2019
Link: https://doi.org/10.1177/..
 
?
9

Impact of apolipoprotein A1‐ or Lecithin:cholesterol acyltr..:

KYPREOS, KYRIAKOS E ; XEPAPADAKI, EVA ; SASSON, SHLOMO...
The FASEB Journal.  33 (2019)  S1 - p. , 2019
Link: https://doi.org/10.1096/..
 
?
10

Impact of apolipoprotein A1- or lecithin:cholesterol acyltr..:

Xepapadaki, Eva ; Maulucci, Giuseppe ; Constantinou, Caterina...
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.  1865 (2019)  6 - p. 1351-1360 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Pharmacological Management of Dyslipidemia in Atheroscleros..:

Kypreos, Kyriakos E. ; Bitzur, Rafael ; Karavia, Eleni A....
Angiology.  70 (2018)  3 - p. 197-209 , 2018
Link: https://doi.org/10.1177/..
 
?
12

Site-specific effects of apolipoprotein E expression on die..:

Hatziri, Aikaterini ; Kalogeropoulou, Christina ; Xepapadaki, Eva...
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.  1864 (2018)  2 - p. 471-480 , 2018
Link: https://doi.org/10.1016/..
 
?
13

The olive constituent oleuropein, as a PPARα agonist, marke..:

Malliou, Foteini ; Andreadou, Ioanna ; Gonzalez, Frank J....
The Journal of Nutritional Biochemistry.  59 (2018)  - p. 17-28 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Lecithin-cholesterol acyltransferase and apolipoprotein A-I..:

Hatziri, Aikaterini ; Kalogeropoulou, Christina ; Karavia, Eleni...
Atherosclerosis.  263 (2017)  - p. e268 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Scavenger Receptor Class B Type I Regulates Plasma Apolipop..:

Karavia, Eleni A. ; Papachristou, Nikolaos I. ; Sakellaropoulos, George C....
Biochemistry.  54 (2015)  36 - p. 5605-5616 , 2015
Link: https://doi.org/10.1021/..
 
1-15